Pharmaceutical company AstraZeneca has established a Science and Technology Integration Office to create partnerships with business, universities, governments and charities, the Daily Telegraph reported on 15 January.
The move is an effort to drive down the costs of developing new medicines.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.